Get the Stockscreener App
39.88
0.52%
-0.25
Xoma Royalty Corp stock is traded at $39.88, with a volume of 45,487.
It is down -0.52% in the last 24 hours and up +50.02% over the past month.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
See More
Previous Close:
$40.13
Open:
$39.95
24h Volume:
45,487
Relative Volume:
0.15
Market Cap:
$475.50M
Revenue:
$52.15M
Net Income/Loss:
$24.35M
P/E Ratio:
27.42
EPS:
1.4544
Net Cash Flow:
$-17.93M
1W Performance:
+8.60%
1M Performance:
+50.02%
6M Performance:
+9.40%
1Y Performance:
+94.45%
1-Day Range:
$39.62
$40.70
1-Week Range:
$35.78
$40.70
52-Week Range:
$20.59
$40.70
Xoma Royalty Corp Stock (XOMA) Company Profile
Name
Xoma Royalty Corp
Sector
Industry
Phone
510-204-7239
Address
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
39.91 | 478.18M | 52.15M | 24.35M | -17.93M | 1.4544 |
VRTX
Vertex Pharmaceuticals Inc
|
441.17 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.34 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
833.10 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.31 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
320.58 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | The Benchmark Company | Buy |
| Apr-29-24 | Initiated | Leerink Partners | Outperform |
| Sep-07-21 | Downgrade | Wedbush | Outperform → Neutral |
| Jun-29-21 | Initiated | Aegis Capital | Buy |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-18-18 | Reiterated | H.C. Wainwright | Buy |
| Oct-17-17 | Resumed | H.C. Wainwright | Buy |
| Sep-05-17 | Upgrade | Wedbush | Neutral → Outperform |
| Jun-12-17 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-11-16 | Reiterated | Wedbush | Outperform |
| Jul-23-15 | Downgrade | Jefferies | Buy → Hold |
| Jul-22-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-22-15 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Oct-10-14 | Resumed | ROTH Capital | Buy |
| Apr-29-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-11-14 | Downgrade | MLV & Co | Buy → Hold |
| Mar-05-14 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-31-13 | Reiterated | MLV & Co | Buy |
| May-09-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-14-12 | Initiated | Cowen & Co | Outperform |
| Mar-31-11 | Reiterated | MLV Capital | Buy |
| Mar-23-11 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-06-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jan-04-11 | Reiterated | Wedbush | Outperform |
View All
Xoma Royalty Corp Stock (XOMA) Latest News
XOMA (XOMA) CFO exercises 4,000 PSUs, 1,632 shares withheld for taxes - Stock Titan
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
Published on: 2026-04-13 23:42:40 - baoquankhu1.vn
XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World
GBIO SEC FilingsGeneration Bio Co. 10-K, 10-Q, 8-K Forms - Stock Titan
Retail Surge: Is now the right time to enter XOMA Royalty Corporation2026 Fundamental Recap & Real-Time Buy Signal Alerts - baoquankhu1.vn
XOMA Stock Price, Quote & Chart | XOMA ROYALTY CORPORATION (NASDAQ:XOMA) - ChartMill
Growth Recap: What is the next catalyst for XOMA Royalty CorporationRate Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
XOMA shares climb after Q4 results top forecasts on strong royalty income - MSN
XOMA SEC FilingsXOMA Royalty Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
XOMA PE Ratio & Valuation, Is XOMA Overvalued - Intellectia AI
XOMA Should I Buy - Intellectia AI
XOMA Royalty Corp (NASDAQ:XOMAO) Stands Out in a High-Growth Stock Screen - ChartMill
XOMA (XOMA) director exercises options, holds 9,234 common shares after trade - Stock Titan
XOMA Royalty (NASDAQ:XOMA) Is Posting Healthy Earnings, But It Is Not All Good News - 富途牛牛
2 Royalty Income Streams You Don’t Have To Work For - Seeking Alpha
XOMA Royalty Corp (NASDAQ:XOMAP) Screened as a High-Growth Stock Using Navellier's Strategy - ChartMill
XOMA Royalty (NASDAQ:XOMA) Stock Passes Above 200 Day Moving AverageHere's Why - MarketBeat
[ARS] XOMA Royalty Corp SEC Filing - stocktitan.net
XOMA Royalty (NASDAQ: XOMA) outlines 2026 meeting, equity and ESPP votes - Stock Titan
Vanguard discloses 0 shares in XOMA after internal realignment (NYSE: XOMA) - stocktitan.net
Director at XOMA Royalty Corp (XOMA) exercises 3,026 stock options - Stock Titan
We Believe XOMA Royalty's (NASDAQ:XOMA) Earnings Are A Poor Guide For Its Profitability - finance.yahoo.com
Bear Alert: What drives XOMA Royalty Corporations stock priceWeekly Profit Analysis & Technical Pattern Based Buy Signals - baoquankhu1.vn
HC Wainwright Reiterates “Buy” Rating for XOMA Royalty (NASDAQ:XOMA) - Defense World
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
XOMA Royalty's (XOMA) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
XOMA Royalty (NASDAQ:XOMA) Issues Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
XOMA Royalty Reports Strong 2025 Financial Results, Expands Portfolio and Anticipates Key 2026 Pipeline Events - Minichart
XOMA Q1 2026 slides: royalty receipts surge 68%, portfolio tops 120 assets - Investing.com Australia
XOMA Q1 2026 slides: royalty receipts surge 68%, portfolio tops 120 assets By Investing.com - Investing.com South Africa
XOMA Royalty Corp 2025 Annual Report: Financials, Nasdaq Listings, and Key Agreements (10-K Filing) - Minichart
XOMA Royalty Q4 Earnings Call Highlights - MarketBeat
XOMA Royalty Declares Quarterly Preferred Stock Dividends - The Manila Times
XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Xoma Royalty 2025 10-K: $52.1M Revenue, $31.7M Net Income - TradingView
XOMA Royalty (NASDAQ: XOMA) grows 2025 royalty cash flow and expands deals - Stock Titan
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock By Investing.com - Investing.com Canada
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock - Investing.com
XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead - Benzinga
XOMA shares jump 7% as strong royalty receipts drive Q4 earnings, revenue beat By Investing.com - Investing.com South Africa
XOMA shares jump 7% as strong royalty receipts drive Q4 earnings, revenue beat - Investing.com
XOMA Royalty (NASDAQ: XOMA) swings to 2025 profit as royalties and milestones surge - Stock Titan
XOMA Royalty Corporation Reports Strong Financial Results and Strategic Developments for Full Year 2025 - Quiver Quantitative
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements - Stock Titan
XOMA Royalty Q4 2025 Earnings Call Transcript - MarketBeat
XOMA (XOMA) CEO granted 126,813 performance units and new RSUs - Stock Titan
XOMA (XOMA) CIO receives stock, PSU grants and updates holdings - Stock Titan
CFO at XOMA (XOMA) receives 138,462 PSUs and 90,000 RSUs - Stock Titan
Equity awards for XOMA (XOMA) Chief Legal Officer include RSUs and PSUs - Stock Titan
Xoma Royalty Corp Stock (XOMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):